Literature DB >> 8400071

Chronic amphotericin nephropathy: morphometric, electron microscopic, and functional studies.

S N Heyman1, I E Stillman, M Brezis, F H Epstein, K Spokes, S Rosen.   

Abstract

The two major hypotheses for the pathogenesis of amphotericin nephrotoxicity are direct interaction with epithelial cell membranes and vasoconstriction. Studies indicating the special vulnerability of the medullary ray and medulla to hypoxia led to a reexamination of amphotericin nephrotoxicity. Twenty-four rats were divided into four groups: amphotericin injection (5 mg/kg daily for 3 wk), amphotericin plus salt depletion, vehicle, and salt depletion and vehicle. The amphotericin group had polyuria (P < 0.01) but normal serum creatinine. In contrast, amphotericin plus salt depletion rats exhibited renal failure (creatinine of 1.49 +/- 0.05 versus amphotericin alone 0.98 +/- 0.01; P < 0.01). Semiquantitative histologic analysis of cortical and medullary injury correlated with functional impairment. Cortical changes in the amphotericin group were largely restricted to the medullary ray, where focal rupture and calcification of thick ascending limbs were noted. The S2/S3 tubules in the medullary rays showed focally diminished cell complexity with histiocytic/lymphocytic infiltration. However, calcification was also seen in the area of the macula densa. Morphometry revealed that the thick ascending limbs in the medulla were hypertrophied (1,420 +/- 63 versus 1,195 +/- 48 microns 2 for vehicle; P < 0.05). In contrast, in the amphotericin and salt depletion group, the changes in the medullary ray extended to the labyrinth and the thick ascending limbs in the inner stripe showed atrophic changes (772 +/- 23 microns 2; P < 0.01 versus vehicle). Thus, changes as a result of amphotericin toxicity take place both in areas known to be most vulnerable to hypoxia (medullary ray and medulla), and in areas rich in oxygen (adjacent to glomerulus). Salt depletion potentiates the cortical changes and converts medullary hypertrophy to atrophy. These findings support a dual pathogenesis for amphotericin nephropathy (direct toxicity and vasoconstriction).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400071     DOI: 10.1681/ASN.V4169

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

1.  PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice.

Authors:  Mei Tran; Denise Tam; Amit Bardia; Manoj Bhasin; Glenn C Rowe; Ajay Kher; Zsuzsanna K Zsengeller; M Reza Akhavan-Sharif; Eliyahu V Khankin; Magali Saintgeniez; Sascha David; Deborah Burstein; S Ananth Karumanchi; Isaac E Stillman; Zoltan Arany; Samir M Parikh
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

2.  Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis.

Authors:  Ritam Sidhu; David B Lash; Arash Heidari; Piruthiviraj Natarajan; Royce H Johnson
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 3.  Drug-induced impairment of renal function.

Authors:  George Sunny Pazhayattil; Anushree C Shirali
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-12-12

4.  Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study.

Authors:  Masato Tashiro; Yoko Obata; Takahiro Takazono; Yuki Ota; Tomotaro Wakamura; Yui Shiozawa; Ai Tsuyuki; Taiga Miyazaki; Tomoya Nishino; Koichi Izumikawa
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

5.  Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study.

Authors:  Yuki Ota; Yoko Obata; Takahiro Takazono; Masato Tashiro; Tomotaro Wakamura; Akinori Takahashi; Yui Shiozawa; Taiga Miyazaki; Tomoya Nishino; Koichi Izumikawa
Journal:  BMC Nephrol       Date:  2021-06-30       Impact factor: 2.388

6.  Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan.

Authors:  Takahiro Takazono; Masato Tashiro; Yuki Ota; Yoko Obata; Tomotaro Wakamura; Taiga Miyazaki; Tomoya Nishino; Koichi Izumikawa
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.